Walleye Capital LLC Pulmonx Corp Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$9.88 - $14.0 $3.68 Million - $5.21 Million
372,290 New
372,290 $3.85 Million
Q3 2022

Nov 14, 2022
SELL
$15.35 - $23.99 $99,744 - $155,887
-6,498 Reduced 19.08%
27,559 $459,000
Q2 2022

Aug 08, 2022
BUY
$14.0 - $27.95 $476,798 - $951,893
34,057 New
34,057 $501,000
Q4 2021

Mar 03, 2022
SELL
$29.72 - $45.1 $242,336 - $367,745
-8,154 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$35.98 - $44.48 $293,380 - $362,689
8,154 New
8,154 $293,000

Others Institutions Holding LUNG

# of Institutions
123
Shares Held
31M
Call Options Held
300
Put Options Held
204K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email